Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q4 FY24 results · Jan–Mar 2024
Medplus Health Services reported revenue from operations of ₹1,490.50 crore (up 19.0% from Q4 FY23) and net profit of ₹33.56 crore (up 26.4% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,490.50 | 1,252.98 | +19.0% | 1,441.47 | +3.4% |
| Other income | 10.46 | 13.69 | −23.6% | 9.79 | +6.8% |
| Total income | 1,500.96 | 1,266.68 | +18.5% | 1,451.26 | +3.4% |
| Profit before tax | 31.98 | 17.25 | +85.4% | 19.96 | +60.2% |
| Net profit for the period | 33.56 | 26.56 | +26.4% | 13.71 | +144.9% |
| Attributable to shareholders of the company | 33.40 | 26.58 | +25.6% | 13.73 | +143.3% |
| EPS, basic (₹) | 2.81 | 2.24 | +25.4% | 1.15 | +144.3% |
| Net margin (%) | 2.3 | 2.1 | 1.0 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 148.37 | 86.95 | +70.6% | 148.10 | +0.2% |
| Other income | 1.90 | 2.54 | −25.3% | 1.82 | +4.1% |
| Total income | 150.27 | 89.49 | +67.9% | 149.92 | +0.2% |
| Profit before tax | 6.32 | 6.59 | −4.0% | 4.24 | +49.0% |
| Net profit for the period | 9.92 | 5.71 | +73.8% | 3.19 | +211.0% |
| EPS, basic (₹) | 0.83 | 0.15 | +453.3% | 0.27 | +207.4% |
| Net margin (%) | 6.7 | 6.6 | 2.2 |
Consolidated
- Filed with BSE
- 29 May 2024, 17:40 IST
- Board meeting
- 28 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 May 2024, 17:40 IST
- Board meeting
- 28 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE